Filing exhibits
- 8-K Current report
- 3.1 Second Amended and Restated Certificate of Incorporation of CERO Therapeutics Holdings, Inc
- 3.2 Second Amended and Restated Bylaws of CERO Therapeutics Holdings, Inc
- 10.7 Investor Rights and Lock-up Agreement, Dated February 14, 2024, by and Between Phoenix Biotech Acquisition Corp. and the Parties Named Therein
- 10.9 Registration Rights Agreement, Dated As of February 14, 2024, by and Between Phoenix Biotech Acquisition Corp., CERO Therapeutics, Inc. and the Investors Named Therein
- 10.11 Registration Rights Agreement, Dated As of February 14, 2024, by and Between CERO Therapeutics Holdings, Inc. and Keystone Capital Partners, LLC
- 10.12 Form of Share Reallocation Agreement, Dated As of February 14, 2024, by and Among Phoenix Biotech Acquisition Corp., Phoenix Biotech Sponsor, LLC and the Parties Named Therein
- 21.1 List of Subsidiaries of CERO Therapeutics Holdings, Inc
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Change in Shell Company Status; Financial Statements and Exhibits
- Download Excel data file
- View Excel data file
Table of Contents